ESTEVE Invests US$108 mn (€100 mn) to Construct New Plant in Spain
Introduction:
ESTEVE plans to invest US$108 mn (€100 mn) to construct new plant in its industrial centre in celrà (girona), Spain.
Features:
The new facility will expand its production capacity for active pharmaceutical ingredients at its primary industrial centre.
This expansion will involve constructing new production and service buildings and installing up to 150 cubic metres of reaction volume. As a result, the current production capacity at the Celrà site will increase by 45 percent, with an additional 15 percent boost in global capacity.
The new unit at the Girona plant marks a significant step forward in the business of developing, manufacturing, and selling active ingredients for third parties (CMO). It will feature advanced technological solutions that enable the production of high-potency active pharmaceutical ingredients and incorporate various innovations in digitalisation and data utilisation.
The unit will also produce several new products, which will be added to the existing portfolio and distributed in major regulated markets, including the United States, Europe, and Japan.
With the new facilities expected to become operational in the last quarter of 2026, the workforce will grow by around 100 employees, adding to the current team of 370 professionals.
Specifications:
| Name | ESTEVE |
| Type | New Construction |
| Budget | US$108 mn (€100 mn) |
| Year | 2026 |
